The efficacy of sacubitril/valsartan in patients receiving peritoneal dialysis with diabetes and heart failure with preserved ejection fraction

Xueyan Bian, Siwei Ma, Qin Su, Qiang Yu, Jiancheng Huang, Sizeng Bao, Ying JiClinical 2024 · DOI

Abstract

The findings suggest that sacubitril/valsartan can safely and effectively improve RRF and cardiac function in patients with diabetes combined with HFpEF receiving PD, but it has little effect on PD adequacy.
BibTeX
@inproceedings{bian2024efficacy,
  author = {Xueyan Bian and Siwei Ma and Qin Su and Qiang Yu and Jiancheng Huang and Sizeng Bao and Ying Ji},
  title = {{The efficacy of sacubitril/valsartan in patients receiving peritoneal dialysis with diabetes and heart failure with preserved ejection fraction}},
  booktitle = {Clinical},
  year = {2024},
  doi = {10.5414/cn111320},
}

Loading related content...

Figure